The launched and completed Joint Transnational Calls (JTC), in translational cancer research, are seven.
Three of them were launched and implemented under the previous TRANSCAN project:
JTC 2011 launched on December 2011 on: "Validation of biomarkers for personalised cancer medicine", 10 projects funded
JTC 2012 launched on December 2012 on: “Translational research on primary and secondary prevention of cancer”, 10 projects funded
JTC 2013 launched on December 2013 on: "Translational research on tertiary prevention in cancer patients", 10 projects funded
The ongoing TRANSCAN-2 project has launched all four calls planned:
JTC 2014 (co-funded by the European Commission) launched on January 2015 on: "Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy", 16 projects funded
JTC 2015 launched on December 2015 on: “Immunology and immunotherapy of cancer: strengthening the translational aspects”, 7 projects funded
JTC 2016 launched on December 2016 on: "Minimally and non-invasive methods for early detection and/or progression of cancer", 14 projects funded
JTC 2017 launched on December 2017 on "Translational research on rare cancers". 12 projects funded
